LH在多囊卵巢综合征患者行IVF-ET中的研究进展
Research Progress of LH in Patients with Polycystic Ovary Syndrome Undergoing IVF-ET
DOI: 10.12677/ACM.2024.143709, PDF,   
作者: 侯美艳, 胥 琴, 转 黎*：昆明理工大学附属医院，云南 昆明；云南省第一人民医院生殖医学中心，云南 昆明；王流林：昆明理工大学附属医院，云南 昆明
关键词: 多囊卵巢综合征(PCOS)；促黄体生成素(LH)；体外受精–胚胎移植(IVF-ET)；Polycystic Ovary Syndrome (PCOS)； Luteinizing Hormone (LH)； In Vitro Fertilization-Embryo Trans-fer (IVF-ET)
摘要: 多囊卵巢综合征(PCOS)是一种常见的内分泌紊乱性疾病，常发生在育龄期女性中。PCOS可以引起排卵障碍、卵巢多囊样改变等，是女性不孕的主要原因之一，严重影响女性的生殖健康。PCOS患者主要通过促排卵治疗，而对于反复促排卵失败的患者，往往需要辅助生殖技术助孕治疗。黄体生成素(LH)可以调节卵泡发育，促进卵子成熟，是衡量卵巢功能的重要指标。现就LH在PCOS患者行体外受精–胚胎移植(IVF-ET)中的应用作一综述。
Abstract: Polycystic ovary syndrome (PCOS) is a common endocrine disorder that often occurs in women of reproductive age. PCOS can cause ovulation disorder and polycystic ovary change, which is one of the main causes of female infertility and seriously affects female reproductive health. PCOS patients are mainly treated by ovulation induction, and for patients with repeated ovulation failure, assisted reproductive technology is often needed to assist pregnancy treatment. Luteinizing hormone (LH) can regulate follicle development, promote egg maturation, and is an important indicator of ovarian function. This article reviews the application of LH in vitro fertilization-embryo transfer (IVF-ET) in PCOS patients.
文章引用：侯美艳, 王流林, 胥琴, 转黎. LH在多囊卵巢综合征患者行IVF-ET中的研究进展[J]. 临床医学进展, 2024, 14(3): 354-359. https://doi.org/10.12677/ACM.2024.143709

参考文献

[1] 杨弘睚, 石永乾, 王茜怡, 等. 多囊卵巢综合征患者INH-B、Leptin、AMH与性激素相关性分析[J]. 中国计划生育学杂志, 2020, 28(7): 1018-1021.
[2] 多囊卵巢综合征诊治路径专家共识编写组. 多囊卵巢综合征诊治路径专家共识[J]. 中华生殖与避孕杂志, 2023, 43(4): 337-345.
[3] Kadoura, S., Alhalabi, M. and Nattouf, A.H. (2022) Conventional GnRH Antagonist Protocols versus Long GnRH Agonist Protocol in IVF/ICSI Cycles of Polycystic Ova-ry Syndrome Women: A Systematic Review and Meta-Analysis. Scientific Reports, 12, Article No. 4456. [Google Scholar] [CrossRef] [PubMed]
[4] Singh, R., Kaur, S., Yadav, S. and Bhatia, S. (2023) Gonadotro-pins as Pharmacological Agents in Assisted Reproductive Technology and Polycystic Ovary Syndrome. Trends in En-docrinology & Metabolism, 34, 194-215. [Google Scholar] [CrossRef] [PubMed]
[5] Barbotin, A.L., Mimouni, N.E.H., Kuchcinski, G., et al. (2023) Hypothalamic Neuroglial Plasticity Is Regulated by Anti-Müllerian Hormone and Disrupted in Polycystic Ovary Syn-drome. eBioMedicine, 90, Article ID: 104535. [Google Scholar] [CrossRef] [PubMed]
[6] Oduwole, O.O., Huhtaniemi, I.T. and Misrahi, M. (2021) The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited. International Journal of Molecular Sciences, 22, Article 12735. [Google Scholar] [CrossRef] [PubMed]
[7] Su, N.J., Huang, C.Y., Liu, J., et al. (2021) Association between Baseline LH/FSH and Live-Birth Rate after Fresh-Embryo Transfer in Polycystic Ovary Syndrome Women. Scientific Reports, 11, Article No. 20490. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, L., Fan, H., Zou, Y., et al. (2021) Aberrant Expression of Long Non-Coding RNAs in Exosomes in Follicle Fluid from PCOS Patients. Frontiers in Genetics, 11, Article 608178. [Google Scholar] [CrossRef] [PubMed]
[9] 邓海花, 莫武宁, 陈美佳, 李炎梅, 柳青, 何敏. 血清抗米勒管激素联合黄体生成素与卵泡刺激素比值对多囊卵巢综合征的诊断价值[J]. 妇儿健康导刊, 2022, 1(6): 7-10.
[10] Hendriks, M.L., Brouwer, J., Hompes, P.G., et al. (2008) LH as a Diagnostic Criterion for Polycystic Ovary Syndrome in Patients with WHO II Oligo/Amenorrhoea. Reproductive BioMedicine Online, 16, 765-771. [Google Scholar] [CrossRef] 
[11] Le, M.T., Le, V.N.S., Le, D.D., et al. (2019) Exploration of the Role of Anti-Mullerian Hormone and LH/FSH Ratio in Diagnosis of Polycystic Ovary Syndrome. Clinical Endocri-nology, 90, 579-585. [Google Scholar] [CrossRef] [PubMed]
[12] 熊伟, 葛军, 况兆忠, 赵芙光. 多囊卵巢综合征患者血清黄体生成素睾酮及抗苗勒管激素表达水平分析[J]. 中国妇幼保健, 2022, 37(11): 2022-2024.
[13] 王大琳, 范东青, 陈芳, 胡艳秋. 辅助生殖中预测卵巢反应性指标的探讨[J]. 中国生育健康杂志, 2019, 30(2): 172-176.
[14] Sunkara, S.K., Rittenberg, V., Raine, Fenning, N., Bhattacharya, S., Zamora, J. and Coomarasamy, A. (2011) Association between the Number of Eggs and Live Birth in IVF Treatment: An Analysis of 400 135 Treatment Cycles. Human Reproduction, 26, 1768-1774. [Google Scholar] [CrossRef] [PubMed]
[15] 刘姗, 马帅, 李媛. GnRH拮抗剂方案促排卵过程中平均LH水平对妊娠结局的影响[J]. 生殖医学杂志, 2022, 31(5): 591-597.
[16] 王小飞, 胡文惠, 涂铵素, 刘蓉. IVF-ET控制性卵巢刺激周期HCG注射日血清LH水平对治疗周期及妊娠结局影响[J]. 中国计划生育学杂志, 2023, 31(1): 148-152, 158.
[17] Malini, N.A. and Roy George, K. (2018) Evaluation of Different Ranges of LH: FSH Ratios in Polycystic Ovarian Syndrome (PCOS)—Clinical Based Case Control Study. General and Comparative Endocrinology, 260, 51-57. [Google Scholar] [CrossRef] [PubMed]
[18] 唐静, 赵梓彤, 李玉梅, 刘冬娥. 不同时期添加黄体生成素对多囊卵巢综合征GnRH-A长方案卵巢慢反应患者临床结局的影响[J]. 湖南师范大学学报(医学版), 2018, 15(4): 56-60.
[19] O’dea, L., O’brien, F., Currie, K., et al. (2008) Follicular Development Induced by Recombinant Luteiniz-ing Hormone (LH) and Follicle-Stimulating Hormone (FSH) in Anovulatory Women with LH and FSH Deficiency: Ev-idence of a Threshold Effect. urrent Medical Research and Opinion, 24, 2785-2793. [Google Scholar] [CrossRef] [PubMed]
[20] Pezzuto, A., Ferrari, B., Coppola, F., et al. (2010) LH Supple-mentation in Down-Regulated Women Undergoing Assisted Reproduction With Baseline Low Serum LH Levels. Gyne-cological Endocrinology, 26, 118-124. [Google Scholar] [CrossRef] [PubMed]
[21] Westergaard, L.G., Laursen, S.B., Andersen, C.Y., et al. (2000) Increased Risk of Early Pregnancy Loss by Profound Suppression of Luteinizing Hormone during Ovarian Stimulation in Normogonadotrophic Women Undergoing Assisted Reproduction. Human Reproduction, 15, 1003-1008. [Google Scholar] [CrossRef] [PubMed]
[22] 阎梦, 华芮, 周瑶, 聂庆文, 李红. 长方案控制性超促排卵过程中黄体生成素水平对多囊卵巢综合征患者IVF-ET结局的影响[J]. 南方医科大学学报, 2016, 36(3): 381-385.
[23] Nakagawa, K., Ohgi, S., Nakashima, A., et al. (2008) The Ratio of Latefollicular to Mid-Follicular Phase LH Concentrations Efficiently Predicts ART Outcomes in Women Undergoing ART Treatment with GnRH-Agonist Long Protocol and Stimulation With Recombinant FSH. Journal of Assisted Reproduction and Genetics, 25, 359-364. [Google Scholar] [CrossRef] [PubMed]
[24] Sun, B., Ma, Y., Li, L., et al. (2021) Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women with Polycystic Ovary Syndrome Undergoing IVF/ICSI. Frontiers in Endocrinology, 11, Article 615957. [Google Scholar] [CrossRef] [PubMed]
[25] Fischer, D., Reisenbüchler, C., Rösner, S., Haussmann, J., Wim-berger, P. and Goeckenjan, M. (2016) Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS. Geburtshilfe und Frauenheilkunde, 76, 718-726. [Google Scholar] [CrossRef] [PubMed]
[26] 赵伟娥, 刘晓娉, 陈攀宇, 梁晓燕, 李晶洁. 多囊卵巢综合征患者基础LH升高对IVF-ET结局影响[J]. 中山大学学报(医学科学版), 2023, 44(1): 78-84.
[27] Barroso, G., Oehninger, S., Monzo, A., Kolm, P., Gibbons, W.E. and Muasher, S.J. (2001) High FSH: LH Ratio and Low LH Levels in Basal Cycle Day 3: Impact on Follicular Development and IVF Outcome. Journal of Assisted Reproduction and Ge-netics, 18, 499-505. [Google Scholar] [CrossRef] 
[28] Kolibianakis, EM.., Kalogeropoulou, L., Griesinger, G., et al. (2007) Among Patients Treated with FSH and GnRH Analogues for in Vitro Fertilization, Is the Addition of Recombinant LH Associated with the Probability of Live Birth? A Systematic Review and Meta-Analysis. Human Reproduction Update, 13, 445-452. [Google Scholar] [CrossRef] [PubMed]

为你推荐